Efficacy, Safety, and Pharmacokinetic of MSC2156119J in Asian Participants With Hepatocellular Carcinoma
Clinical trial NCT01988493 · COMPLETED
Trial details
- NCT number
- NCT01988493
- Sponsor
- Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-06
- Primary completion
- 2018-02-05
- Enrollment
- 117
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.